Hold LIN with 10-15% tactical trim and active collar hedge into $473 SMA binary resolution
Four consecutive LIN Hold calls show deteriorating alpha trajectory (+0.5%, -0.1%, -2.5%, -1.0%) resolving toward bearish end; 8/11 lesson explicitly criticized unexecuted collars and reactive risk management. The convergence of deteriorating alpha trajectory, unresolved binary $473 SMA event, 8/11 collar lesson, and asymmetric confirmation requirements (bulls need multi-week multi-condition vs bears need single close below $473.73) dictates Hold with 10-15% trim (lower end per MCD lesson), active collar execution, and explicit re-engagement clock. Hard invalidation: decisive close below $473.73 on volume >3M with expanding MACD and RSI < 30 → finish exit on remainder.
| Position | Action |
|---|---|
| Current positioning in rangebound technical regime with binary $473.73 SMA event unresolved | Trim 10-15% at current $478 (per MCD 8/12 lesson: default to lower end of trim range) |
| Post-trim remainder position | Move stop to $468 (just below lower Bollinger at $471.29, respecting $10.54 ATR) |
| Core position post-trim with deteriorating alpha trajectory across four consecutive LIN Hold calls (+0.5%, -0.1%, -2.5%, -1.0%) | Execute protective collar ($515 calls / $470 puts) at ~1-1.5% notional cost rather than leaving as optional guidance |
Technical price action diverges from record-breaking fundamentals; the pullback to the rising 200 SMA on a defensive compounder with secular semiconductor tailwinds, proven pricing power, and a shrinking share count is a buying opportunity, not a breakdown signal.
| Indicator | Value | Signal |
|---|---|---|
| Close | $478.20 | neutral |
| Open | $479.86 | neutral |
| High | $483.29 | neutral |
| Low | $475.76 | neutral |
| Volume | 1,980,970 | neutral |
| 200 SMA | $473.73 | bearish |
| 50 SMA | $510.91 | bearish |
| 10 EMA | $488.60 | bearish |
| MACD Line | -8.79 | bearish |
| MACD Signal | -7.28 | bearish |
| MACD Histogram | -1.51 | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: 50 SMA re-entry at $510.91
Then: Evaluate momentum chasing risk — conservative analyst identifies this as momentum chasing in reverse
The pullback to the rising 200 SMA is textbook mean-reversion accumulation, not a breakdown signal
↩ rebuts: “Bear's 'CRITICAL' support warning and HOLD/SELL recommendation”
EV: +14% (to July peak at $546) · concedes: Respects the technical analysis work and acknowledges the 12.9% drawdown and bearish chart patterns; Concedes RSI is at lower bound of its range (though argues this is decelerating bearish momentum, not capitulation); Acknowledges oil +86% YTD as an 'input cost watch item' (but argues pass-through clauses protect margins); Acknowledges the 5.22M volume day (though reframes it as single-event capitulation, not distribution); Concedes LIN lagged the broader market over 12 months (though argues defensive beta is designed to do so); The bear's technicals accurately describe what has happened; the bull argues they don't predict what will happen
The 200 SMA test at $473.73 is a distribution event, not accumulation; FCF compression, 85% debt increase, and a 30x multiple in a higher-for-longer rate regime create asymmetric downside risk that the bull's "patient capital" narrative fails to address.
EV: -$420 to $440 (realistic bear case) vs +$510.91 to $546 (bull case requiring multi-week reversal) · concedes: The business is high quality; The fundamentals are excellent in terms of revenue, EPS, and backlog; The bull's patient capital framing has merit over very long holding periods
→ vs conservative: Conservative valuation objection overstates static P/E concerns (30.87x trailing, 24.43x forward, 2.09x PEG, 5.64x book); 26% expected EPS growth can compress forward multiple without requiring higher share price, and LIN's infrastructure moat (on-site systems, customer qualifications, take-or-pay contracts) justifies premium unlike generic chemicals companies
→ vs conservative: Capex of $5.26 billion and net debt of $23.115 billion represent investment in competitive moat ahead of structural AI/fab demand cycle, not speculative borrowing; operating cash flow of $10.35 billion and net debt 1.8x EBITDA demonstrate funding from mature contracted cash engine
→ vs neutral: Waiting for RSI above 40, MACD positive, reclaim of $497.54 20-day and $510.91 50-day averages requires 2.5-6.8% upside movement before action, risking momentum chase instead of buying at favorable support test; $471 hard stop is only 0.6% below 200-day average and smaller than $10.54 ATR, meaning normal daily move can trigger it
→ vs neutral: Key 200-day SMA ($473.73) is rising and has not failed; current situation is a support test, not confirmed fundamental breakdown; more meaningful invalidation requires decisive high-volume close below 200-day average followed by failure to reclaim
| RSI | 33.82 | bearish |
| Bollinger Upper Band | $523.79 | neutral |
| Bollinger Middle Band (20 SMA) | $497.54 | neutral |
| Bollinger Lower Band | $471.29 | bearish |
| ATR | $10.54 | bearish |
| Recent Peak (07/02) | $546.64 | neutral |
| Recent Trough (08/13) | $475.76 | neutral |
| Peak-to-Trough Decline | ~12.9% | bearish |
Support: 475.76 · 471.29 · 473.73 | Resistance: 490 · 497.54 · 510.91 · 523.79
LIN is in a confirmed short-to-medium-term downtrend approaching a critical test of the 200 SMA at $473.73, approximately $4.47 below the current close. The stock exhibits triple bearish alignment with price below the 10 EMA ($488.60) and 50 SMA ($510.91), confirmed by MACD bearish crossover (line at -8.79 vs signal at -7.28) and expanding negative histogram. RSI at 33.82 is near oversold but lacks reversal signals. The 07/31 gap-down on elevated volume (5.22M shares vs 2M average) marked capitulation, with subsequent bounces failing on declining volume—a classic distribution signature. A decisive break below the 200 SMA ($473.73) would signal a major trend reversal. Tactical recommendations suggest HOLD/SELL for existing positions with stops just below $473.73, while new entries should await reclaim of the 50 SMA with volume confirmation and RSI bullish reversal above 40.
Market Cap
$220.44B
Beta
0.726
P/E (TTM)
30.87
Forward P/E
24.43
PEG Ratio
2.09
P/B
5.64
Dividend Yield
1.30%
Share Price (implied)
~$478
52-Week High
$548.20
52-Week Low
$387.78
50-Day Avg
$511.30
200-Day Avg
$475.55
Revenue 2022
$33,364M
Revenue 2023
$32,854M
Revenue 2024
$33,005M
Revenue 2025
$33,986M
Gross Margin 2022
41.7%
Gross Margin 2023
46.7%
Gross Margin 2024
48.1%
Gross Margin 2025
48.8%
Operating Margin 2022
19.4%
Operating Margin 2023
24.7%
Operating Margin 2024
26.0%
Operating Margin 2025
27.2%
EBITDA 2022
$9,962M
EBITDA 2023
$12,217M
EBITDA 2024
$12,836M
EBITDA 2025
$13,124M
Net Income 2022
$4,147M
Net Income 2023
$6,199M
Net Income 2024
$6,565M
Net Income 2025
$6,898M
Diluted EPS 2022
$8.23
Diluted EPS 2023
$12.59
Diluted EPS 2024
$13.62
Diluted EPS 2025
$14.61
EPS (TTM)
$15.49
Forward EPS
$19.57
D&A 2022
$4,204M
D&A 2025
$3,763M
Q2 2025 Revenue
$8,495M
Q2 2026 Revenue
$9,289M
Q2 2025 Diluted EPS
$3.73
Q2 2026 Diluted EPS
$4.15
Q2 2025 Operating Margin
27.5%
Q2 2026 Operating Margin
27.3%
Q2 2025 Net Income
$1,766M
Q2 2026 Net Income
$1,928M
Revenue (TTM)
$35.45B
Gross Profit (TTM)
$17.14B
EBITDA (TTM)
$13.82B
Net Income (TTM)
$7.24B
Operating Margin (TTM)
28.1%
Profit Margin (TTM)
20.4%
ROE (TTM)
18.4%
ROA (TTM)
7.16%
Current Ratio
0.879
Debt/Equity
68.9%
Total Assets 2025
$86,817M
Total Assets Q2 2026
$88,349M
Goodwill + Intangibles 2025
$39,798M
Net PPE 2024
$25,764M
Net PPE 2025
$29,393M
Net PPE Q2 2026
$29,170M
Total Debt 2025
$28,069M
Total Debt Q2 2026
$28,013M
Net Debt 2025
$21,933M
Net Debt Q2 2026
$23,115M
Stockholders' Equity 2025
$38,245M
Stockholders' Equity Q2 2026
$40,630M
Cash 2025
$5,056M
Cash Q2 2026
$4,898M
Working Capital 2025
$-1,873M
Working Capital Q2 2026
$-1,950M
Construction in Progress 2024
$4.1B
Construction in Progress 2025
$6.1B
Tangible Book Value 2025
-$1.55B
Treasury Stock 2025
$11,561M
Treasury Stock Q2 2026
$12.9B
OCF 2022
$8,864M
OCF 2023
$9,305M
OCF 2024
$9,423M
OCF 2025
$10,350M
CapEx 2022
$3,173M
CapEx 2023
$3,787M
CapEx 2024
$4,497M
CapEx 2025
$5,261M
FCF 2022
$5,691M
FCF 2023
$5,518M
FCF 2024
$4,926M
FCF 2025
$5,089M
Dividends Paid 2022
$2,344M
Dividends Paid 2023
$2,482M
Dividends Paid 2024
$2,655M
Dividends Paid 2025
$2,811M
Buybacks 2022
$5,168M
Buybacks 2023
$3,958M
Buybacks 2024
$4,482M
Buybacks 2025
$4,601M
Acquisitions 2022
$110M
Acquisitions 2023
$953M
Acquisitions 2024
$317M
Acquisitions 2025
$412M
Q2 2026 OCF
$2,271M
Q2 2026 CapEx
$1,438M
Q2 2026 FCF
$833M
Cost of Revenue 2025
$17.39B
SGA 2025
$3.43B
RD 2025
$147M
Net Interest Expense 2025
$255M
Total Capital Return 2025
$7.41B
Revenue CAGR 5Y
~2%
Net Income CAGR 5Y
~18%
EPS CAGR 5Y
~21%
Revenue YoY Q2 2026
+9.3%
EPS YoY Q2 2026
+11.3%
Strengths
Concerns
Linde plc is a mega-cap industrial gases and engineering company ($220.44B market cap) with exceptional margin expansion (gross margins up 710 bps to 48.8% since 2022) driven by pricing power, energy cost recovery, and mix shift toward specialty/electronic gases. Q2 2026 demonstrated record performance with $9.29B revenue (+9.3% YoY) and $4.15 EPS (+11.3% YoY), validating the project backlog conversion thesis. The company generates $10.35B in operating cash flow (2025) but is strategically deploying $5.26B annually in capex for clean hydrogen and electronics gas projects, suppressing free cash flow near $5B. Capital return is robust at $7.41B (2025), combining dividends and aggressive buybacks, while the defensive profile (beta 0.73, take-or-pay contracts) supports the quality compounder positioning despite premium valuation (P/E 30.87x).
Macro: Risk-on global backdrop: S&P 500 and TSX at record highs on benign inflation, Fed on hold (86% prob of zero cuts in 2026), low U.S. recession odds (8%), oil elevated (+86% YTD) with Strait of Hormuz jitters, and semiconductor capex super-cycle intact as major chipmakers (TSMC, Samsung) face low nationalization risk on prediction markets.